September 2026
The US peptide therapeutics market size stood at USD 22.63 billion in 2026, with major US peptide therapeutics market companies including AbbVie, GlaxoSmithKline plc., Amgen, Inc.
July 2026
The peptide therapeutics market size is expected to increase from USD 52.59 billion in 2025 to nearly USD 87.21 billion by 2035 with a notable CAGR of 5.19%.
January 2026
The global peptide-based cancer therapeutics market size was evaluated at USD 9.47 billion in 2025 and is predicted to hit around USD 24.85 billion by 2035, growing at a CAGR of 10.13%.
September 2026
The pruritus therapeutics market size stood at USD 12.26 billion in 2026, with major pruritus therapeutics market companies including Bristol-Myers Squibb, Novartis AGÂ , Pfizer Inc.,Teva Pharmaceuticals.
September 2026
The infectious disease therapeutics market size is calculated at USD 37.67 billion in 2026 and is expected to hit around USD 53.48 billion by 2035 at a CAGR of 3.97%.
September 2026
The global Duchenne muscular dystrophy therapeutics market size was evaluated at USD 7.80 billion in 2026 and is predicted to hit around USD 26.88 billion by 2035, growing at a CAGR of 14.80%.
June 2026
The global peptide therapeutics CDMO market is growing as pharma and biotech companies outsource complex peptide drug development and manufacturing.
May 2026
The global peptide therapeutics contract API manufacturing market size is estimated to hit around USD 9.02 billion by 2035 from USD 4.19 billion in 2026, at a CAGR of 9.02%.
September 2026
The next-generation RNA therapeutics market is growing with innovations in RNA-based drugs, improving treatments for cancer, genetic diseases, and infectious conditions.
September 2026
The lung cancer therapeutics market size totalled USD 38.23 billion in 2026, with major lung cancer therapeutics market players including AstraZeneca, BoehringerIngelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Hoffmann-La Roche, Merck & Co, Pfizer Inc.
September 2026
The global non-Hodgkin's lymphoma therapeutics market size is estimated to hit around USD 20.94 billion by 2034, increasing from USD 11.80 billion in 2026, with a CAGR of 7.43%.
September 2026
The peptide synthesis market size was valued at USD 732.58 million in 2026 and is expected to attain around USD 1,438.78 million by 2035 with a CAGR of 7.81%.
September 2026
The global injectable peptides drugs market size was evaluated at USD 53.07 billion in 2026 and is predicted to hit around USD 117.18 billion by 2035, growing at a CAGR of 9.20%.
June 2026
The global alzheimer therapeutics market size is evaluated at USD 7.79 billion in 2026 and is predicted to hit around USD 38.61 billion by 2035, growing at a CAGR of 19.52%.
June 2026
The global rheumatology therapeutics market size is evaluated at USD 51.82 billion in 2025 and is predicted to hit around USD 68.49 billion by 2035, growing at a CAGR of 2.83%.
June 2026
The global psychedelic therapeutics market size is estimated to hit around USD 12.40 billion by 2035 increasing from USD 2.94 billion in 2025, with a CAGR of 15.48%.
June 2026
The global exosome therapeutics market size is evaluated at USD 928.93 thousand in 2025 and is predicted to hit around USD 4,564.32 thousand by 2035, with a CAGR of 17.26%.
March 2026
The global allergy diagnostics and therapeutics market size is expected to hit around USD 75.07 billion by 2035 from USD 38.76 billion in 2025 with a CAGR of 6.83%.
January 2026
The global oral protein and peptide market size was evaluated at USD 9.43 billion in 2025 and is predicted to hit around USD 47.63 billion by 2035, growing at a CAGR of 17.58%.
January 2026
The global hepatitis therapeutics market size is calculated at USD 17.80 billion in 2025 and is projected to hit around USD 27.80 billion by 2035 with a CAGR of 4.56%.
December 2025
The osteoarthritis therapeutics market size accounted for USD 10.84 billion in 2025 and is expected to hit around USD 26.31 billion by 2035 with a CAGR of 9.27%.
July 2025
The global nucleic acid therapeutics market size reached USD 5.77 billion in 2024 and is projected to surpass around USD 17.02 billion by 2034 with a solid CAGR of 11.42%.
July 2025
The pet cancer therapeutics market size was estimated at USD 448.03 million in 2023 and is projected to surpass around USD 1,150.70 million by 2034 with a CAGR of 9.89%.
July 2025
The asthma therapeutics market size was estimated at USD 29.87 billion in 2024 and is projected to hit around USD 51.03 billion by 2034, with a notable CAGR of 5.50%.
July 2025
The U.S. mRNA therapeutics market size was estimated at USD 5.48 billion in 2025 and is projected to hit USD 12.70 billion by 2036, with a notable CAGR of 8.77%
July 2025
The global protein therapeutics market size was estimated at USD 375.26 billion in 2024 and is projected to hit around USD 741.16 billion by 2034 with a CAGR of 7.04%.
September 2026
The sinus dilation devices market size is estimated at USD 3.98 billion in 2026 and is predicted to hit around USD 8.94 billion by 2035 with a CAGR of 9.59%.
September 2026
The reusable laparoscopic instruments market reached USD 3.73 billion in 2026, with key reusable laparoscopic instruments market companies including Medtronic PLC, Johnson & Johnson (Ethicon), Karl Storz SE & Co. KG
September 2026
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
September 2026
The infectious disease vaccines market size reached USD 41.60 billion in 2026, with leading infectious disease vaccines market companies including Pfizer, Moderna, Johnson & Johnson (Janssen), GlaxoSmithKline (GSK).
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com